Table 2 Baseline echocardiographic and laboratory findings
Parameter | Study group mean ± SD / median [IQR] |
|---|---|
Echocardiography: | |
LVEF (%) | 50.0 [29.0–62.0] |
LVEDd (mm) | 56.0 [49.5–65.0] |
LVEDvol (mL) | 111.5 [79.0–182.3] |
LVEDvol /BSA | 58.4 [43.2–91.4] |
IVSDd (mm) | 10.0 [10.0–11.8] |
PWDd (mm) | 10.0 [9.0–11.0] |
LAvol. (mL) | 100.0 [71.3–126.0] |
LAvol./BSA | 53.0 [38.2–65.5] |
RVSP (mmHg) | 43.0 [39.0–53.5] |
TAPSE (mm) | 22.0 ± 6.8 |
Mitral valve annulus (mm) | 37.4 ± 6.4 |
Vena contracta (mm) | 6.0 [5.0–7.0] |
PISA radius (mm) | 6.0 [5.0–7.0] |
Mitral regurgitation volume (ml/beat) | 23.0 [17.0–31.0] |
ERO (cm2) | 0.15 [0.10–0.22] |
Laboratory tests: | |
creatinine (mmol/L) | 1.03 [0.83–1.22] |
eGFR (mL/min/1.73 m2) | 67.11 ± 24.09 |
albumins (g/L) | 4.00 [3.72–4.22] |
total proteins (g/L) | 6.52 ± 0.69 |
C-reactive protein:(mg/L) | 2.80 [1.10–8.47] |
NT-proBNP (pg/ml) | 1815.0 [583.5–3483.3] |